Dr. Julianna Olah, CTO of Psyrin, conducted cutting-edge research during her doctoral studies at King's College London, building the foundation of Psyrin's scientific approach to voice analysis in mental health. This study, published in Schizophrenia Research in 2023, evaluated the utility of acoustic voice markers across different mental health conditions.
Voice analysis has emerged as a promising frontier in mental health assessment due to its non-invasive nature and potential for remote, large-scale deployment. Changes in vocal expression and speech patterns have long been recognized as key features of psychotic disorders, particularly schizophrenia. Traditional assessments often require in-person clinical evaluations, limiting access and potentially introducing bias. Voice-based digital biomarkers offer the possibility of more objective, accessible, and scalable assessments, especially relevant for young populations who are comfortable with technology.
Methodology
For this study, Dr. Olah and her team collected data from 441 participants in the general population who were asked to describe images while their speech was recorded online via their own devices. This innovative methodology allowed for larger and more diverse sampling than traditional laboratory settings. Participants also completed assessments for schizotypy (using the Schizotypal Personality Questionnaire), depression (Patient Health Questionnaire), and generalized anxiety (Generalized Anxiety Disorder Assessment). The researchers extracted 88 acoustic parameters from these speech samples using advanced speech processing techniques.
- Speech features alone explained ~24% of the variability in schizotypy scores
- Adding demographic factors raised this to ~30%
- Including depression and anxiety symptoms raised predictive power to ~44%
- Most influential acoustic features: loudness parameters, Hammerberg index, spectral flux, and slope measurements
Clinical Implications
There was substantial overlap between the acoustic markers most predictive of schizotypy, depression, and anxiety. This finding suggests that many speech alterations previously attributed to psychotic disorders may actually reflect broader psychological distress or comorbid conditions. Future clinical applications must control for comorbid conditions to ensure accurate assessment of specific disorders.
When the researchers analyzed schizotypy subdomains separately, they found that cognitive-perceptual symptoms (resembling positive symptoms like unusual perceptions) showed less acoustic overlap with depression and anxiety than interpersonal and disorganized symptoms did.
The implications for clinical practice are considerable. Voice-based assessments could potentially supplement traditional clinical interviews, offering objective, quantitative data to track symptom progression and treatment response. Particularly in early intervention settings, where subtle speech changes might precede more obvious symptoms, acoustic analysis could aid in identifying individuals who might benefit from preventive interventions.
The Future of Digital Phenotyping
This research aligns with broader trends toward digital phenotyping in psychiatry — using technology to measure behavior objectively and continuously. Voice analysis joins other modalities like smartphone interaction patterns, sleep monitoring, and social media usage as potential windows into mental health status. Together, these approaches promise a more nuanced, dimensional understanding of psychiatric conditions that moves beyond traditional diagnostic categories toward precision psychiatry.